|
CN100390178C
(zh)
|
1999-11-12 |
2008-05-28 |
拜奥根Idec马萨诸塞公司 |
作为腺苷受体拮抗剂的多环烷基嘌呤
|
|
WO2002062389A1
(en)
|
2001-02-08 |
2002-08-15 |
Ono Pharmaceutical Co., Ltd. |
Remedies for urinary diseases comprising lpa receptor controlling agents
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
WO2011017350A2
(en)
|
2009-08-04 |
2011-02-10 |
Amira Pharmaceuticals, Inc. |
Compounds as lysophosphatidic acid receptor antagonists
|
|
GB2474120B
(en)
|
2009-10-01 |
2011-12-21 |
Amira Pharmaceuticals Inc |
Compounds as Lysophosphatidic acid receptor antagonists
|
|
GB2474748B
(en)
|
2009-10-01 |
2011-10-12 |
Amira Pharmaceuticals Inc |
Polycyclic compounds as lysophosphatidic acid receptor antagonists
|
|
TW201120016A
(en)
|
2009-12-08 |
2011-06-16 |
Abbott Lab |
Novel oxadiazole compounds
|
|
EP3360552A1
(en)
*
|
2010-12-07 |
2018-08-15 |
Amira Pharmaceuticals, Inc. |
Polycyclic lpa1 antagonist and uses thereof
|
|
EA201390821A1
(ru)
|
2010-12-07 |
2013-10-30 |
Амира Фармасьютикалс, Инк. |
Антагонисты рецепторов лизофосфатидной кислоты и их применение
|
|
WO2012138648A1
(en)
|
2011-04-06 |
2012-10-11 |
Irm Llc |
Compositions and methods for modulating lpa receptors
|
|
WO2013070879A1
(en)
|
2011-11-10 |
2013-05-16 |
Bristol-Myers Squibb Company |
Methods for treating spinal cord injury with lpa receptor antagonists
|
|
SG11201406526WA
(en)
|
2012-04-27 |
2014-11-27 |
Novartis Ag |
Cyclic bridgehead ether dgat1 inhibitors
|
|
SG11201407228PA
(en)
|
2012-06-20 |
2014-12-30 |
Hoffmann La Roche |
N-aryltriazole compounds as lpar antagonists
|
|
UA109868C2
(ru)
|
2012-06-20 |
2015-10-12 |
Ф. Хоффманн-Ля Рош Аг |
Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
|
|
WO2014113485A1
(en)
|
2013-01-15 |
2014-07-24 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
|
US8962660B2
(en)
*
|
2013-03-14 |
2015-02-24 |
Bristol-Myers Squibb Company |
Oxabicyclo [2.2.2] acid GPR120 modulators
|
|
DK2988743T3
(da)
|
2013-03-15 |
2021-03-01 |
Epigen Biosciences Inc |
Heterocykliske forbindelser, der kan anvendes til behandling af sygdom
|
|
AR108838A1
(es)
|
2016-06-21 |
2018-10-03 |
Bristol Myers Squibb Co |
Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa
|
|
JP7212047B2
(ja)
|
2017-12-19 |
2023-01-24 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｌｐａアンタゴニストとしてのシクロヘキシル酸ピラゾールアゾール
|
|
CN111699180B
(zh)
|
2017-12-19 |
2024-11-29 |
百时美施贵宝公司 |
作为lpa拮抗剂的吡唑n-连接的氨基甲酰基环己基酸
|
|
WO2019126089A1
(en)
|
2017-12-19 |
2019-06-27 |
Bristol-Myers Squibb Company |
Cyclohexyl acid pyrazole azines as lpa antagonists
|
|
US11180488B2
(en)
|
2017-12-19 |
2021-11-23 |
Bristol-Myers Squibb Company |
Isoxazole o-linked carbamoyl cyclohexyl acids as LPA antagonists
|
|
EP3728209B1
(en)
|
2017-12-19 |
2025-12-24 |
Bristol-Myers Squibb Company |
Cyclohexyl acid isoxazole azines as lpa antagonists
|
|
EP4011875A1
(en)
|
2017-12-19 |
2022-06-15 |
Bristol-Myers Squibb Company |
Triazole n-linked carbamoyl cyclohexyl acids as lpa antagonists
|
|
KR102756639B1
(ko)
|
2017-12-19 |
2025-01-16 |
브리스톨-마이어스 스큅 컴퍼니 |
Lpa 길항제로서의 시클로헥실 산 이속사졸 아졸
|
|
US11447475B2
(en)
|
2017-12-19 |
2022-09-20 |
Bristol-Myers Squibb Company |
Isoxazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
|
|
CN112041302B
(zh)
|
2017-12-19 |
2024-11-19 |
百时美施贵宝公司 |
作为lpa拮抗剂的吡唑o-连接的氨基甲酰基环己基酸
|
|
ES2946657T3
(es)
|
2018-09-18 |
2023-07-24 |
Bristol Myers Squibb Co |
Acidos ciclopentílicos como antagonistas de LPA
|
|
US20220041572A1
(en)
|
2018-09-18 |
2022-02-10 |
Bristol-Myers Squibb Company |
Cycloheptyl acids as lpa antagonists
|